Waters Corporation

Stocks

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - NYSE Other stock markets 04:00:02 2026-06-08 pm EDT			After hours 08:00:00 pm
363.34 ^USD	-0.55%		352.09	-3.10%

Jun. 03	Waters Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 10:30 AM
Jun. 03	Waters Corporation Announces FDA 510(k) Clearance Of BD BACTEC FXI Culture System	CI

Waters Corporation Reports Earnings Results for the First Quarter Ended April 04, 2026

Published on 05/05/2026 at 08:23 am EDT - Modified on 05/05/2026 at 11:30 am EDT

S&P Capital IQ

WATERS CORPORATION

-0.55%

Waters Corporation reported earnings results for the first quarter ended April 04, 2026. For the first quarter, the company reported sales was USD 1,267 million compared to USD 662 million a year ago. Net loss was USD 72 million compared to net income of USD 121 million a year ago.

Basic loss per share from continuing operations was USD 0.87 compared to basic earnings per share from continuing operations of USD 2.04 a year ago. Diluted loss per share from continuing operations was USD 0.87 compared to diluted earnings per share from continuing operations of USD 2.03 a year ago.

Latest news about Waters Corporation

Jun. 03	Waters Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 10:30 AM
Jun. 03	Waters Corporation Announces FDA 510(k) Clearance Of BD BACTEC FXI Culture System	CI
Jun. 03	HSBC Adjusts Price Target on Waters to $435 From $415, Maintains Buy Rating	MT
Jun. 02	BofA Securities Adjusts Price Target on Waters to $400 From $370	MT
Jun. 01	Waters Corporation Unveils Cyclic Ims P20 Ms	CI
Jun. 01	Waters Corporation Introduces Xevo Mrt P10 Mass Spectrometer with Enhanced Sensitivity and Speed	CI
May. 14	Wells Fargo Adjusts Price Target on Waters to $370 From $355, Maintains Equalweight Rating	MT
May. 07	Becton Dickinson raises 2026 profit forecast on drug delivery devices demand	RE
May. 07	Becton Dickinson raises annual profit forecast on strength in drug delivery devices	RE
May. 06	Deutsche Bank Adjusts Price Target on Waters to $350 From $330	MT
May. 06	UBS Adjusts Price Target on Waters to $375 From $330, Maintains Neutral Rating	MT
May. 06	Analyst recommendations: AMD, KKR, PayPal Holdings, Arista Networks, and TransDigm Group.
May. 06	TD Cowen Adjusts Price Target on Waters to $385 From $345	MT
May. 05	US Equity Markets End Higher as US Says Iran Ceasefire Holds, Oil Falls	MT
May. 05	Waters Corporation, Q1 2026 Earnings Call, May 05, 2026

Chart Waters Corporation

Duration

Period

WAT: Dynamic Chart

Company Profile

Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (62.3%): chromatographic analysis instruments (56% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (30.6%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (13.4%); - services (37.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.1%), industrial (30.7%), academic institutions and governmental agencies (11.2%). Net sales are distributed geographically as follows: the United States (31.6%), Americas (6.2%), China (13.4%), Japan (5.3%), Asia (14%) and Europe (29.5%).

Employees

7,900

Sector

Advanced Medical Equipment & Technology

More about the company